@article{c82324ce15734cebb423af2fde008e98,
title = "Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation",
abstract = "Risk factors including cardiometabolic and endocrine disorders have a significant impact on atrial remodeling causing atrial fibrillation (AF). Diabetes mellitus and hyperthyroidism are strong independent risk factors for AF and worsen outcomes of rhythm control strategies. An early diagnosis and intervention for these risk factors combined with rhythm control strategies may improve the overall cardiovascular mortality and morbidity. This review summarizes the current state of knowledge about the AF risk factors diabetes mellitus and thyroid disease, and discusses the impact of the modification of these risk factors on primary and secondary prevention of AF.",
keywords = "Atrial fibrillation, Diabetes mellitus, Risk factors, Thyroid disease",
author = "Satoshi Higa and Akira Maesato and Sugako Ishigaki and Kazuyoshi Suenari and Chen, {Yi Jen} and Chen, {Shih Ann}",
note = "Funding Information: Dr S. Higa is a consultant to Japan Life Line and Johnson & Johnson; and received speaker's honoraria from Japan Life Line, Medtronic, Abbott, Bayer, Biotronik, Boehringer-Ingelheim, Bristol-Myers, Daiichi-Sankyo Pharmaceutical Company, and Pfizer. The other authors have nothing to declare. Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",
year = "2021",
month = mar,
doi = "10.1016/j.ccep.2020.11.005",
language = "English",
volume = "13",
pages = "63--75",
journal = "Cardiac Electrophysiology Clinics",
issn = "1877-9182",
publisher = "W.B. Saunders Ltd",
number = "1",
}
